MicroDose Therapeutx Inc. Company Profile

MicroDose Therapeutx is a privately-held specialty pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuses on developing proprietary products that address large unmet market opportunities, and on drug delivery platforms for the pulmonary, oral and transdermal delivery of medications. The company develops its products and technologies independently, as well as in partnership with leading pharmaceutical companies. MicroDoseâs products and platforms currently target respiratory disease states such as asthma, COPD and RSV disease, as well as constipation and diabetes among others.
News Articles
MicroDose Therapeutx, Moerae Matrix deal
MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled ...
MicroDose Therapeutx Announces Successful Conclusion of Safety Study in Asthmatic Patients for ...
[Moerae Matrix] partners with [MicroDose] for DPI delivery of MMI0100
[Moerae Matrix Inc.] (fibrotic disease therapeutics) has teamed up with [MicroDose Therapeutx Inc.] (drug delivery platforms) to deliver Moerae's preclinical MMI0100 as a dry powder inhalation (DPI) t...
Gilead Cuts Deal With MicroDose
Gilead Sciences (NASDAQ: GILD) said today it has obtained a license from MicroDose Therapeutx to an inhalable small molecule drug for respiratory syncytial virus (RSV). Foster City-based Gilead agreed...
MicroDose completes third and final MDT-637 Phase 1 study on RSV infection
MicroDose Therapeutx, Inc., announced today the completion of its third and final Phase 1 clinical study for MDT-637 with its novel inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RS...
MicroDose Therapeutx, Inc., announced today the completion of its third and final Phase 1 clinical study for MDT-637 with its novel inhaled antiviral fusion inhibitor, MDT-637,...
FDA clears Philips’ MicroDose SI mammography system
Royal Philips Electronics today announces 510(k) clearance from the Food and Drug Administration (FDA) for its MicroDose SI system, the first full-field digital mammography (FFDM) system on the market...
Drugs and Medications
None
PubMed Articles
Novel strategies for microdose studies using non-radiolabeled compounds.
Microdose studies using non-radiolabeled compounds enable assessment of the clinical pharmacokinetics of drug candidates in humans without the need to synthesize radiolabeled compounds. We have demons...
PURPOSE: To investigate the potency of LC-MS/MS by means of sensitivity and the applicability for cassette dosing in microdose clinical trials. METHODS: Thirty one top-selling 31 drugs were spiked to...
Because the effectiveness of the "microdose flare" stimulation protocol often is attributed to the dramatic endogenous gonadotropin release induced by the GnRH agonist, the aim of this study was to de...
A clinical study was conducted to assess the ability of a microdose (100μg) to predict the human pharmacokinetics (PK) following a therapeutic dose of clarithromycin, sumatriptan, propafenone, parace...
Approaches using molecular imaging technology - use of PET in clinical microdose studies.
Positron emission tomography (PET) imaging uses minute amounts of radiolabeled drug tracers and thereby meets the criteria for clinical microdose studies. The advantage of PET, when compared to other...
Clinical Trials
Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633
This study is a first administration to man microdose study to describe the pharmacokinetics of GSK2239633.
An Exploratory Phase 1 Microdose Study of PRX-105
Exploratory phase 1, first in human, open label, non-randomized, single-dose study of PRX-105, administered intravenously by slow bolus injection to 10 healthy volunteers. The objective i...
This study is a methodology study to evaluate a microdose strategy for Drug-Drug Interaction (DDI) which will be useful in the evaluation of the backup compounds for GSK706769, as well as...
The primary objective of this study is to assess the absolute bioavailability and to evaluate pharmacokinetic parameters of a single oral dose and a radiolabelled intravenous microdose of...
Patients who have undergone in vitro fertilization (IVF) and produced four or less follicles or had four or less oocytes (eggs) retrieved are often referred to as poor responders. We will...
Companies
MicroDose Therapeutx is a privately-held specialty pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuse...
MicroDose Therapeutx is a privately-held pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuses on devel...
MicroDose Technologies, Inc. is a privately held premier drug delivery and specialty pharmaceuticals company. Founded in 1998, MicroDose is pioneering the use of proprietary drug delivery platforms fo...
More Information about "MicroDose Therapeutx Inc." on BioPortfolio
We have published hundreds of MicroDose Therapeutx Inc. news stories on BioPortfolio along with dozens of MicroDose Therapeutx Inc. Clinical Trials and PubMed Articles about MicroDose Therapeutx Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MicroDose Therapeutx Inc. Companies in our database. You can also find out about relevant MicroDose Therapeutx Inc. Drugs and Medications on this site too.